World journal of urologyHumansBotulinum ToxinsType AAdministrationIntravesical
Using intravesical botulinum toxin as an adjunct during urologic surgery: a systematic review.
Suditi Rahematpura, Joanna Marantidis, Amanda Wibben, Hannah Romeo, Kate MacRae, Isha Kalaga, Rachael D Sussman
Published: 202610.1007/s00345-025-06136-9
Abstract
PURPOSE: Intravesical onabotulinum toxin-A (BTX-A) has been studied as a curative therapy for overactive bladder (OAB), neurogenic bladder, and interstitial cystitis. Limited evidence supports adjunctive BTX-A during urologic surgeries to reduce blad…
Preview only. Read the full abstract at the source